Certain embodiments of the invention pertain to pharmaceutical compositions comprising a cationic nonribosomal peptide (CNRP) or a salt thereof. Certain other embodiments of the invention pertain to methods of treating a bacterial infection in a subject by administering to the subject a CNRP or a salt thereof.